Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PKDL”

10 trials

Showing 10 of 10 results

Testing effectiveness (Phase 2)Study completedNCT01635777
What this trial is testing

Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL)

Who this might be right for
PKDL
AB Foundation 37
Large-scale testing (Phase 3)Study completedNCT02193022
What this trial is testing

Miltefosine for Children With PKDL

Who this might be right for
Post Kala Azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 80
Post-approval studies (Phase 4)Study completedNCT03311607
What this trial is testing

Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
Medecins Sans Frontieres, Netherlands 280
Early research (Phase 1)Study completedNCT00982774
What this trial is testing

Safety and Immunogenicity of the LEISH-F2 + MPL-SE Vaccine With SSG for Patients With PKDL

Who this might be right for
Post Kala Azar Dermal Leishmaniasis
Access to Advanced Health Institute (AAHI) 42
Testing effectiveness (Phase 2)WithdrawnNCT04107961
What this trial is testing

Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
University of York
Post-approval studies (Phase 4)Study completedNCT01975051
What this trial is testing

Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 36
Testing effectiveness (Phase 2)Study completedNCT03969134
What this trial is testing

Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL

Who this might be right for
Leishmaniasis, Cutaneous
University of York 86
Very early researchStudy completedNCT06251739
What this trial is testing

Repurposing Ivermectin for PKDL Treatment

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 30
Very early researchStudy completedNCT07286604
What this trial is testing

Ivermectin Repurposed for the Treatment of PKDL

Who this might be right for
Post Kala Azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 10
Testing effectiveness (Phase 2)UnknownNCT03399955
What this trial is testing

Short Course Regimens for Treatment of PKDL (Sudan)

Who this might be right for
PKDL - Post-Kala-Azar Dermal Leishmanioid
Drugs for Neglected Diseases 110

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation